Jenerise Ltd Partners with Nutrilution to Launch Jenerise Cr.01™ in India

Jenerise Ltd, developer and owner of the branded creatine ingredient Jenerise Cr.01™, has entered into an exclusive commercial agency agreement with Nutrilution Co., Ltd. to initiate the regional rollout of its precision-grade creatine monohydrate ingredient, starting with India as the launch market.

Under this partnership, Nutrilution will act as the key strategic growth partner and commercial agent, tasked with identifying, vetting, introducing, and facilitating market entry across dietary supplement, food, and nutritional product sectors in India.

Key leaders driving this regional expansion and overseeing strategic execution include Nutrilution Co-Founders Alan Johnstone and Jing Sun.

Strategic Objectives & India Market Entry

The partnership focuses on introducing Jenerise Cr.01™ to top-tier Indian consumer health brands and ingredient manufacturers. Rather than positioning creatine solely as a traditional sports supplement, the launch will focus on education-led promotion that reframes creatine as a foundational cellular energy nutrient for muscle, brain, and overall health across all stages of life.

Key focus areas for the India expansion include:

  • High-Profile Brand Collaborations: Identifying and onboarding pioneer Indian health and wellness brands to integrate Jenerise Cr.01™ into high-growth finished consumer products.

  • Regulatory Vetting & Compliance Support: Utilising Nutrilution’s local market insights to navigate regulatory compliance frameworks under the Food Safety and Standards Authority of India (FSSAI) and the Central Drugs Standard Control Organisation (CDSCO).

  • Commercial Supply Chain Setup: Establishing reliable, scalable supply chain pathways and delivery frameworks (including FOB/CIF logistics models) to ensure seamless supply for Indian brand partners.

  • Education-Led Promotion: Utilising scientific data dossiers and clinical research to support brand partners in driving consumer awareness around creatine’s broader cognitive and cellular benefits.

Technical Superiority & Verification Standards

Jenerise Cr.01™ introduces a high standard of purity, verification, and performance to the Indian functional ingredient market:

  • <99.95% Content Assay: Independent-verified lot-by-lot standard that exceeds standard pharmaceutical benchmarks.

  • Minimal Contaminants: Guaranteed lot-by-lot testing with zero Cyanide or DHT detected, and DCD levels capped at 8 ppm.

  • Rapid Solubility: Engineered at the particle level during manufacturing to achieve 30–40 second solubility, dissolving clear and sediment-free across various product formats. Currently available in both 80 and 200 mesh.

  • Lot-by-Lot Transparency: Fully documented third-party certification provided for every batch, enabling customer-facing transparency.

Strategic Growth Horizon

By combining Jenerise’s technical heritage and research base in creatine innovation with Nutrilution’s commercial network, regional insights, and business development capabilities in Asia, both companies aim to build a strong presence for Jenerise Cr.01™ in India before expanding across broader regional territories.

For commercial opportunities, brand collaborations, and distribution inquiries regarding the Indian market, don't hesitate to get in touch with Alan Johnstone directly at alan@nutrilution.com.

For media relations, press materials, and interview requests, please reach out to Rachael Jennings at rachel@jenerise.com.

Stay Connected to the Future of Creatine Supplementation

Jenerise is on a mission to drive the next evolution of human wellness and make precision-grade creatine as foundational to daily health as protein. To follow our journey, hear directly from our leadership team, and get the latest updates on our global rollout, subscribe to our weekly founders’ newsletter right here.

Next
Next

Jenerise Heads to Fi Europe in Frankfurt to Support Fayrefield Nutratek's UK & Western EU Cr.01 Activation